Drake reignites Kendrick Lamar beef: Label hits back at sensational claims of illegal ...
Drake and Kendrick Lamar’s twisted war of words is far from over. In a fierce plot twist, the Canadian rapper has launched a legal action against Universal Music Group, which interestingly distributes ...
The American Journal of Managed Care9 小时
FDA Approves Acoramidis for ATTR-CM
With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...
BridgeBio price target raised to $49 from $43 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on BridgeBio (BBIO) to $49 from $43 and keeps a Buy rating on the shares. Acoramidis received ...
BridgeBio Pharma’s Promising Prospects: FDA Approval of Attruby and Strategic Pricing ...
In a report released yesterday, Tiago Fauth from Wells Fargo maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price ...
JD Supra15 小时
FDA’s Drug Review Gold Standard
Robert F. Kennedy Jr., President-elect Trump’s nominee for secretary of health and human services, has said one of his mandates from ...